Galena Biopharma, Inc. Stockholders Encouraged to Contact Securities Law Firm about Investigation

DALLAS, March 24, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Galena Biopharma, Inc. (NasdaqCM:GALE). Concerned GALE investors who purchased between November 6, 2013 and February 14, 2014 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

"The complaint alleges that Galena Biopharma, Inc. failed to disclose or misrepresented that The Dream Team Group was hired to promote the share price of GALE, which according to the complaint purportedly allowed the CEO to sell $3.8 million worth of stock," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed to Galena Biopharma, Inc. shareholders." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] or 877-819-8033 with questions or concerns.

Hamilton Lindley  
DEANS & LYONS LLP 
325 North Saint Paul Street, Suite 1500 
Dallas, TX 75201 
Phone: 214-736-7861 
Fax: 214-965-8505 
Toll-free: 877-819-8033
[email protected] 
www.deanslyons.com

SOURCE Deans & Lyons LLP